Find a Doctor

Find a Researcher

Pranita D Tamma, M.D., M.P.H.

Associate Professor of Pediatrics

Female

Expertise

Pediatric Infectious Diseases

Research Interests

Diagnosing and treating multidrug-resistant infections; improving antibiotic use among children and adults ...read more

Locations

The Johns Hopkins Hospital (Main Entrance)

1800 Orleans St.
Sheikh Zayed Tower
Baltimore, MD 21287 map

Phone: 410-614-1492

Johns Hopkins Harriet Lane Clinic

200 N. Wolfe Street
Rubenstein Child Health Building, Suite 3149
Baltimore, MD 21287 map

Phone: 410-614-3917

Background

Pranita Tamma is an Associate Professor of Pediatrics in the Division of Pediatric Infectious Diseases at The Johns Hopkins University School of Medicine. As Medical Director of Antimicrobial Stewardship, she assists clinicians with optimizing the selection of antibiotics to improve patient outcomes while minimizing antibiotic-associated harm. She is the recipient of federal research funding that focuses on improving our understanding of the mechanisms of gram-negative bacterial resistance, improving available diagnostics to identify gram-negative resistant pathogens, and optimizing therapeutic choices for infections caused by multidrug-resistant gram-negative organisms, including novel therapies like phage therapy.

Titles

Associate Professor of Pediatrics

Departments / Divisions

Pediatrics - Infectious Diseases

Education

Degrees

MD; SUNY Downstate Medical Center (2004)

Residencies

Pediatrics; Johns Hopkins University School of Medicine (2007)

Fellowships

Pediatric Infectious Diseases; Johns Hopkins University School of Medicine (2011)

Board Certifications

American Board of Pediatrics (Pediatric Infectious Diseases) (2011)

Research & Publications

Selected Publications

View all on PubMed

Simner PJ. Bergman Y, Conzemius R, Jacobs E, Tekle T, Beisken S, Tamma PD. An NDM-Producing Escherichia coli Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Towards Pan-β-Lactam Resistance. Open Forum Infect Dis. 2023

Tamma PD, Souli M, Billard M, Campbell J, Conrad D, Ellison DW, Evans B, Evans SR, Greenwood-Quaintance KE, Filippov AF, Geres HS, Hamasaki T, Komarow L, Nikolich MP, Lodise TP, Nayak SU, Norice- Tra C, Patel R, Pride D, Russell J, Van Tyne D, Chambers HF, Fowler VG, Schooley RT. Safety and Microbiological Activity of Phage Therapy in Persons with Cystic Fibrosis Colonized with Pseudomonas aeruginosa: Study Protocol for a Phase 1b/2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Trials. 2022;23(1):1057

Simner PJ, Mostafa HH, Bergman Y, Ante M, Tekle T, Adebayo A, Beisken S, Dzintars K, Tamma PD. Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy Is Associated with Increased blaNDM-5 Copy Number and Gene Expression. Clin Infect Dis. 2022;75(1):47-54.

Amoah J, Klein EY, Chiotos K, Cosgrove SE, *Tamma PD. Administration of a β-lactam Prior to Vancomycin as the First Dose of Antibiotic Therapy Improves Survival in Patients with Bloodstream Infections. Clin Infect Dis. 2022;75(1):98-104

Tamma PD, Beisken S, Bergman Y, Posch AE, Avdic E, Sharara S, Cosgrove SE, Simner PJ. Modifiable Risk Factors for the Emergence of Ceftolozane-Tazobactam Resistance. Clin Infect Dis. 2021;73(11):e4599-e4606.

Activities & Honors

Honors

National Gale and Ira Drukier Prize in Children’s Health Research, Weill Cornell Medicine

Memberships

Society for Healthcare Epidemiology of America, 2009
The Pediatric Infectious Diseases Society, 2008
Infectious Diseases Society of America, 2008

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile